DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

Incyte Corp (NASDAQ: INCY)

72.26 1.35 (1.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

INCY $72.26 1.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.97
Previous Close $70.91
Daily Range $68.31 - $74.54
52-Week Range $64.51 - $133.62
Market Cap $13.4B
P/E Ratio -144.71
Dividend (Yield) $0.00 (0.0%)
Volume 3,028,336
Average Daily Volume 2,541,593
Current FY EPS -$0.18

Sector

Healthcare

Industry

Drug Makers

Incyte Corp (INCY) Description

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/

News & Commentary

Shares of Incyte Corporation Plummeted in January -- Here's Why

A midstage trial for Incyte came to a grinding halt in January, but the company may have a far bigger concern to contend with down the line.

VXF, LNKD, INCY, BMRN: ETF Outflow Alert

Incyte (INCY): Today's Weak On High Volume Stock

The Math Shows QQQ Can Go To $129

Biotech Stock Roundup: Biogen, Amgen Top Estimates; Zika Virus Grabs Attention

Questioning The Bearish Narrative Surrounding NewLink's IMPRESS Trial

Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line

A potential approval this year of a drug that may work better than Humira could imperil sales of the company's best-seller.

Despite Target Cuts, Analysts Stick With Incyte for Big Upside

Incyte Halts Phase II Jakafi-Stivarga Combination Study

Why Incyte's Shares Crashed 12% Today

The company has decided to halt a study of Jakafi in colorectal cancer.

See More INCY News...

INCY's Top Competitors

INCY $72.26 (1.90%)
Current stock: INCY
AMGN $143.16 (0.11%)
Current stock: AMGN
GILD $87.25 (2.33%)
Current stock: GILD
BIIB $249.99 (-0.31%)
Current stock: BIIB